CCK-A receptor inhibitor 1
[Lys4] Sarafotoxin S6c
POT-4
PMX 205
NRP1 antagonist 2
Dehydrodiisoeugenol
Rutaecarpine
Rebamipide-d4
Celecoxib-d7
Gallic acid hydrate
Isoorientin
Rofecoxib
Piroxicam
Parecoxib Sodium
Acamprosate calcium
Otenaproxesul
Lumiracoxib
Tenoxicam
Gnetol
Oxaprozin
Ampyrone
Amfenac Sodium Hydrate
Hexahydrocurcumin
Zaltoprofen
N-Methylcytisine
Isoxicam
(E)-Ethyl p-methoxycinnamate
TFAP
Nepafenac
Ophiopogonin D
H-D-Ser-OH
Pagoclone
Fmoc-NMe-PEG4-C2-acid
Boc-NH-PEG12-NH2
NH-bis(PEG4-Boc)
Biotin-PEG2-C6-azide
GNE-502
m-PEG3-OH
Propargyl-PEG4-Boc
Myrislignan
N,N',N''-Triacetylchitotriose
N,N'-Diacetylchitobiose
N-3-hydroxydecanoyl-L-Homoserine lactone
N-Benzyllinoleamide
N-Desmethyl Galanthamine
Propyphenazone
Ketoprofen(lysinate)
COX-2-IN-27
COX-2-IN-26
Sphondin
Heterophdoid A
COX-2-IN-19
COX-2-IN-23
Floctafenine
COX-2-IN-14
Teriflunomide impurity 3
COX-2/PI3K-IN-2
COX-2-IN-20
COX-2/PI3K-IN-1
N-{1-[1-(1-adamantylcarbonyl)-4-piperidinyl]-1H-pyrazol-5-yl}tetrahydro-3-furancarboxamide(36574079)
